{"transactions":[{"id":1427520,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2024-08-20T18:05:08.000Z","date":"2024-08-19","kind":"exercise","planned":false,"acquired":false,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying the option became vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":4350,"derivative":{"exercise_price":2.5,"expiration_date":"2033-09-28","underlying":"Common Stock, par value $0.0001","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001104659-24-091346","document":"tm2422185-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465924091346/tm2422185-1_4seq1.xml","form_type":"4"}},{"id":1427519,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2024-08-20T18:05:08.000Z","date":"2024-08-19","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the option became vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-24-091346","document":"tm2422185-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465924091346/tm2422185-1_4seq1.xml","form_type":"4"}},{"id":1427518,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2024-08-20T18:05:08.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":8184,"price":6.88,"value":56305.92,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale represents shares sold to cover the exercise price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President."}],"balance_after":55524,"source":{"system":"sec-edgar","filing":"0001104659-24-091346","document":"tm2422185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465924091346/tm2422185-1_4seq1.xml","form_type":"4"}},{"id":1427517,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2024-08-20T18:05:08.000Z","date":"2024-08-19","kind":"exercise","planned":false,"acquired":true,"shares":21750,"price":2.5,"value":54375.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares received upon exercise were immediately transferred to Pacific Biopharma Associates, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President."}],"balance_after":63708,"source":{"system":"sec-edgar","filing":"0001104659-24-091346","document":"tm2422185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465924091346/tm2422185-1_4seq1.xml","form_type":"4"}},{"id":1427516,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2024-08-20T18:05:08.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":7827,"price":6.93,"value":54241.11,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale represents shares sold to cover the exercise price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President."}],"balance_after":41958,"source":{"system":"sec-edgar","filing":"0001104659-24-091346","document":"tm2422185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465924091346/tm2422185-1_4seq1.xml","form_type":"4"}},{"id":1427515,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2024-08-20T18:05:08.000Z","date":"2024-08-19","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":2.6,"value":52000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares received upon exercise were immediately transferred to Pacific Biopharma Associates, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President."}],"balance_after":49785,"source":{"system":"sec-edgar","filing":"0001104659-24-091346","document":"tm2422185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465924091346/tm2422185-1_4seq1.xml","form_type":"4"}},{"id":1771450,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2023-09-29T17:01:55.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":26100,"derivative":{"exercise_price":2.5,"expiration_date":"2033-09-28","underlying":"Common Stock, par value $0.0001","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001104659-23-105401","document":"tm2327241-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465923105401/tm2327241-7_4seq1.xml","form_type":"4"}},{"id":1807272,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2023-08-15T18:46:57.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":2.875,"value":862.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001104659-23-092080","document":"tm2323899-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465923092080/tm2323899-1_4seq1.xml","form_type":"4"}},{"id":1937826,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2023-03-27T17:17:23.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":9000,"price":4.27,"value":38430.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.265 to $4.28, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 20,151 shares of Common Stock previously owned directly by the reporting person which were transferred to Pacific Biopharma Associates, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President."}],"balance_after":29484,"source":{"system":"sec-edgar","filing":"0001104659-23-037190","document":"tm2310588d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465923037190/tm2310588d1_4seq1.xml","form_type":"4"}},{"id":2108475,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-11-21T16:05:18.000Z","date":"2022-11-18","kind":"exercise","acquired":false,"shares":139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split that occurred on September 13, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split that occurred on September 13, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split that occurred on September 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.4,"expiration_date":"2022-12-31","underlying":"Common Stock, par value $0.0001","underlying_shares":139},"source":{"system":"sec-edgar","filing":"0001104659-22-120752","document":"tm2231089-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922120752/tm2231089-1_4seq1.xml","form_type":"4"}},{"id":2108474,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-11-21T16:05:18.000Z","date":"2022-11-18","kind":"exercise","acquired":true,"shares":139,"price":2.4,"value":333.6,"ownership":{"direct":true},"balance_after":20151,"source":{"system":"sec-edgar","filing":"0001104659-22-120752","document":"tm2231089-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922120752/tm2231089-1_4seq1.xml","form_type":"4"}},{"id":2148638,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-09-30T21:22:35.000Z","date":"2022-09-29","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 29, 2022, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":23500,"derivative":{"exercise_price":12.62,"expiration_date":"2032-09-29","underlying":"Common Stock, par value $0.0001","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001104659-22-104780","document":"tm2227177-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922104780/tm2227177-6_4seq1.xml","form_type":"4"}},{"id":2229864,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-16T21:27:23.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":1000,"price":8,"value":8000.0,"ownership":{"direct":true},"balance_after":20012,"source":{"system":"sec-edgar","filing":"0001104659-22-072059","document":"tm2218746d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922072059/tm2218746d1_4.xml","form_type":"4"}},{"id":2256641,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-05-25T19:00:27.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":1200,"price":4.5,"value":5400.0,"ownership":{"direct":true},"balance_after":19012,"source":{"system":"sec-edgar","filing":"0001104659-22-064786","document":"tm2216827-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922064786/tm2216827-1_4seq1.xml","form_type":"4"}},{"id":2391686,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-02-16T21:10:11.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":139,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of January 18, 2017, as amended on March 29, 2017, the Issuer assumed all outstanding options to purchase shares of Altimmune, Inc. capital stock on a 0.749106:1 basis upon closing of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person holds a stock option granted on May 4, 2017 for 139 shares of common stock with an exercise price of $17.7 per share and an expiration date of December 31, 2023 (the \"2023 Stock Option\"). The 2023 Stock Option was previously reported as covering 4,177 shares at an exercise price of $0.59 per share, but was adjusted to reflect a one-for-thirty reverse stock split that occurred on September 13, 2018. On May 4, 2017, the reporting person mistakenly filed a Form 4 reporting that the 2023 Stock Option had an expiration date of December 31, 2022. The 2023 Stock Option has an expiration date of December 31, 2023."}],"balance_after":139,"derivative":{"exercise_price":17.7,"exercise_date":"2017-05-04","expiration_date":"2023-12-31","underlying":"Common Stock, par value $0.0001","underlying_shares":139},"source":{"system":"sec-edgar","filing":"0001104659-22-024420","document":"tm226968-1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922024420/tm226968-1_4a.xml","form_type":"4/A","original_submission_date":"2022-01-26"}},{"id":2391685,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-02-16T21:10:11.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":139,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person holds a stock option granted on May 4, 2017, which is exercisable for 139 shares of common stock with an exercise price of $2.40 per share and an expiration date of December 31, 2022 (the \"2022 Stock Option\"). The 2022 Stock Option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split that occurred on September 13, 2018. On January 26, 2022, the reporting person mistakenly filed a Form 4 reporting the exercise of the 2022 Stock Option for 70 shares of common stock. Such exercise did not occur. As of January 25, 2022, the reporting person owned only 17,812 shares of common stock and there were 139 shares of common stock unexercised and underlying the 2022 Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of January 18, 2017, as amended on March 29, 2017, the Issuer assumed all outstanding options to purchase shares of Altimmune, Inc. capital stock on a 0.749106:1 basis upon closing of the merger."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person holds a stock option granted on May 4, 2017, which is exercisable for 139 shares of common stock with an exercise price of $2.40 per share and an expiration date of December 31, 2022 (the \"2022 Stock Option\"). The 2022 Stock Option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split that occurred on September 13, 2018. On January 26, 2022, the reporting person mistakenly filed a Form 4 reporting the exercise of the 2022 Stock Option for 70 shares of common stock. Such exercise did not occur. As of January 25, 2022, the reporting person owned only 17,812 shares of common stock and there were 139 shares of common stock unexercised and underlying the 2022 Stock Option."}],"balance_after":139,"derivative":{"exercise_price":2.4,"exercise_date":"2017-05-04","expiration_date":"2022-12-31","underlying":"Common Stock, par value $0.0001","underlying_shares":139},"source":{"system":"sec-edgar","filing":"0001104659-22-024420","document":"tm226968-1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922024420/tm226968-1_4a.xml","form_type":"4/A","original_submission_date":"2022-01-26"}},{"id":2425092,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-01-26T19:00:54.000Z","date":"2022-01-25","kind":"exercise","acquired":false,"shares":70,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."}],"balance_after":69,"derivative":{"exercise_price":2.4,"expiration_date":"2022-12-31","underlying":"Common Stock, par value $0.0001","underlying_shares":70},"source":{"system":"sec-edgar","filing":"0001104659-22-007911","document":"tm224587-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922007911/tm224587-1_4.xml","form_type":"4"}},{"id":2425091,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-01-26T19:00:54.000Z","date":"2022-01-25","kind":"exercise","acquired":true,"shares":70,"price":2.4,"value":168.0,"ownership":{"direct":true},"balance_after":17882,"source":{"system":"sec-edgar","filing":"0001104659-22-007911","document":"tm224587-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465922007911/tm224587-1_4.xml","form_type":"4"}},{"id":2471479,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2021-12-15T19:00:38.000Z","date":"2021-12-14","kind":"exercise","acquired":false,"shares":139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.4,"expiration_date":"2022-01-03","underlying":"Common Stock, par value $0.0001","underlying_shares":139},"source":{"system":"sec-edgar","filing":"0001104659-21-150119","document":"tm2135595-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465921150119/tm2135595-1_4seq1.xml","form_type":"4"}},{"id":2471478,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2021-12-15T19:00:38.000Z","date":"2021-12-14","kind":"exercise","acquired":true,"shares":139,"price":2.4,"value":333.6,"ownership":{"direct":true},"balance_after":17812,"source":{"system":"sec-edgar","filing":"0001104659-21-150119","document":"tm2135595-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465921150119/tm2135595-1_4seq1.xml","form_type":"4"}},{"id":2502664,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2021-11-19T19:00:35.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":70,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 2,090 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 2,090 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was previously reported as covering 2,090 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.4,"expiration_date":"2021-12-03","underlying":"Common Stock, par value $0.0001","underlying_shares":70},"source":{"system":"sec-edgar","filing":"0001104659-21-142052","document":"tm2133565-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465921142052/tm2133565-1_4seq1.xml","form_type":"4"}},{"id":2502663,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2021-11-19T19:00:35.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":70,"price":2.4,"value":168.0,"ownership":{"direct":true},"balance_after":17673,"source":{"system":"sec-edgar","filing":"0001104659-21-142052","document":"tm2133565-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465921142052/tm2133565-1_4seq1.xml","form_type":"4"}},{"id":2559810,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2021-09-24T20:45:31.000Z","date":"2021-09-23","kind":"grant","acquired":true,"shares":24100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 23, 2021, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":24100,"derivative":{"exercise_price":15.44,"expiration_date":"2031-09-23","underlying":"Common Stock, par value $0.0001","underlying_shares":24100},"source":{"system":"sec-edgar","filing":"0001104659-21-119482","document":"tm2128463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000110465921119482/tm2128463-1_4seq1.xml","form_type":"4"}},{"id":2977338,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2020-11-17T19:00:32.000Z","date":"2020-11-13","kind":"exercise","acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 7, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 7, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.4,"expiration_date":"2020-12-30","underlying":"Common Stock","underlying_shares":60},"source":{"system":"sec-edgar","filing":"0000899243-20-031318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924320031318/doc4.xml","form_type":"4"}},{"id":2977337,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-11-17T19:00:32.000Z","date":"2020-11-13","kind":"exercise","acquired":true,"shares":60,"price":2.4,"value":144.0,"ownership":{"direct":true},"balance_after":17603,"source":{"system":"sec-edgar","filing":"0000899243-20-031318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924320031318/doc4.xml","form_type":"4"}},{"id":3005096,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (\"RSUs\")","published_at":"2020-10-16T19:00:13.000Z","date":"2020-09-24","kind":"exercise","acquired":false,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16850},"source":{"system":"sec-edgar","filing":"0000899243-20-028538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924320028538/doc4.xml","form_type":"4"}},{"id":3005095,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-10-16T19:00:13.000Z","date":"2020-09-24","kind":"exercise","acquired":true,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17543,"source":{"system":"sec-edgar","filing":"0000899243-20-028538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924320028538/doc4.xml","form_type":"4"}},{"id":3021663,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2020-09-28T18:00:16.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":25500,"derivative":{"exercise_price":12.03,"expiration_date":"2030-09-24","underlying":"Common Stock, par value $0.0001","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0000899243-20-026411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924320026411/doc4.xml","form_type":"4"}},{"id":3097490,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (\"RSUs\")","published_at":"2020-06-29T21:54:07.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date."}],"balance_after":16850,"derivative":{"underlying":"Common Stock","underlying_shares":16850},"source":{"system":"sec-edgar","filing":"0000899243-20-017835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924320017835/doc4.xml","form_type":"4"}},{"id":3703833,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2019-01-04T17:07:21.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001012975-19-000033","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000101297519000033/edgar.xml","form_type":"4"}},{"id":4184769,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2017-10-17T20:07:12.000Z","date":"2017-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":2.5,"exercise_date":"2018-04-30","expiration_date":"2027-10-13","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001012975-17-000761","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000101297517000761/edgar.xml","form_type":"4"}},{"id":4225464,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-08-24T16:48:59.000Z","date":"2017-08-23","kind":"purchase","acquired":true,"shares":5000,"price":2.2679,"value":11339.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $2.23 to $2.28 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price."}],"balance_after":30777,"source":{"system":"sec-edgar","filing":"0001012975-17-000656","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000101297517000656/edgar.xml","form_type":"4"}},{"id":4225463,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-08-24T16:48:59.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":5000,"price":2.1515,"value":10757.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $2.08 to $2.16 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price."}],"balance_after":25777,"source":{"system":"sec-edgar","filing":"0001012975-17-000656","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000101297517000656/edgar.xml","form_type":"4"}},{"id":4329962,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-08T20:31:01.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":4177,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":4177,"derivative":{"exercise_price":0.59,"exercise_date":"2017-05-04","expiration_date":"2022-12-31","underlying":"Common Stock, par value $0.0001","underlying_shares":4177},"source":{"system":"sec-edgar","filing":"0000899243-17-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924317012354/doc4.xml","form_type":"4"}},{"id":4329961,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-08T20:31:01.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":4178,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":4178,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2022-12-31","underlying":"Common Stock, par value $0.0001","underlying_shares":4178},"source":{"system":"sec-edgar","filing":"0000899243-17-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924317012354/doc4.xml","form_type":"4"}},{"id":4329960,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-08T20:31:01.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":4178,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":4178,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2022-01-03","underlying":"Common Stock, par value $0.0001","underlying_shares":4178},"source":{"system":"sec-edgar","filing":"0000899243-17-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924317012354/doc4.xml","form_type":"4"}},{"id":4329959,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-08T20:31:01.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":2090,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":2090,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2021-12-03","underlying":"Common Stock, par value $0.0001","underlying_shares":2090},"source":{"system":"sec-edgar","filing":"0000899243-17-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924317012354/doc4.xml","form_type":"4"}},{"id":4329958,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-08T20:31:01.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1791,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":1791,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2020-12-30","underlying":"Common Stock, par value $0.0001","underlying_shares":1791},"source":{"system":"sec-edgar","filing":"0000899243-17-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924317012354/doc4.xml","form_type":"4"}},{"id":4329957,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-08T20:31:01.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1791,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":1791,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2020-06-08","underlying":"Common Stock, par value $0.0001","underlying_shares":1791},"source":{"system":"sec-edgar","filing":"0000899243-17-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924317012354/doc4.xml","form_type":"4"}},{"id":4329956,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-08T20:31:01.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":4755,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":4755,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2020-06-08","underlying":"Common Stock, par value $0.0001","underlying_shares":4755},"source":{"system":"sec-edgar","filing":"0000899243-17-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924317012354/doc4.xml","form_type":"4"}},{"id":4329955,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":88183,"kind":"person","name":"Drutz David","position":1,"cik":"0001428764","reported_name":"Drutz David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-05-08T20:31:01.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":20777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001  on a 0.749106:1 basis upon the closing of the merger."}],"balance_after":20777,"source":{"system":"sec-edgar","filing":"0000899243-17-012354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428764/000089924317012354/doc4.xml","form_type":"4"}}]}